Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Can these fallen small-cap angels regain their wings?
    • Opinion

    Can these fallen small-cap angels regain their wings?

    One of the trickiest aspects of investing is deciding whether a fallen angel will ever fly again. If they do regain their wings, the rewards of buying in at distressed levels can be enormous. But as they impress on newcomers in Masterchef safety briefings, trying to catch a falling knife can be highly injurious. As

    Read More
    Public
  • AssetOwl signs first Victorian real estate agency for virtual inspection platform
    • News

    AssetOwl signs first Victorian real estate agency for virtual inspection platform

    Amid functional changes in the real estate market which have been accelerated by the pandemic, property tech company AssetOwl (ASX: AO1) has signed their first Victorian real estate agency for their virtual inspection platform Pirsee. Signing of the agency, which AssetOwl has chosen not to name, comes after a nine month partnership with the Real

    Read More
    Public
  • Acquisitions elevate listed administration minnow into a Class of its own
    • News

    Acquisitions elevate listed administration minnow into a Class of its own

    Over the last decade, the role of the typical public accountant has morphed from the old number-crunching, box-ticking role to that of being a value-adding custodian of their clients’ wealth. Behind the ‘fun’ part of dispensing sage counsel, quotidian functions need to be fulfilled to ensure legal and corporate compliance and the smooth running of

    Read More
    Public
  • Little Green Pharma enters race to treat mental illness with psychedelic medicines
    • News

    Little Green Pharma enters race to treat mental illness with psychedelic medicines

    Advancing their research and development for medicinal cannabis applications, Little Green Pharma (ASX: LGP) has joined the global movement for use of psychedelics for treatment of mental illness having secured regulatory approval to supply psilocybin. The approvals come in the form of a Schedule 9 licence granted by the WA Department of Health which enables

    Read More
    Public
  • Patents granted for Orthocell’s suture-less method of soft tissue repair
    • News

    Patents granted for Orthocell’s suture-less method of soft tissue repair

    The earliest known use of surgical sutures dates back to 3000 BC in ancient Egypt. Since then humans have experimented with sutures made from flax, cotton, hair, tendons, silk and anything vaguely thread-like. Taking surgical suturing to the next level is Orthocell (ASX: OCC), a Western Australian based company developing next-gen regenerative medicine products. The

    Read More
    Public
  • AnteoTech signs distribution rights in Turkey for their rapid COVID-19 test
    • News

    AnteoTech signs distribution rights in Turkey for their rapid COVID-19 test

    Companies the world over are pooling their strengths to address COVID-19, one of the most important global challenges of our time. Seeking to help in the field of rapid point of care testing, AnteoTech (ASX: ADO) is applying their proprietary technology to create the EuGeni COVID-19 Antigen Rapid Test.  The Company has signed a distribution

    Read More
    Public
  • «
  • ‹
  • 463
  • 464
  • 465
  • 466
  • 467
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.